SOHO 2022: Biology and Treatment of LGL Leukemia

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

SOHO 2022: Biology and Treatment of LGL Leukemia

By SOHO 2022 Tenth Annual Meeting FEATURING Thomas Loughran

166 views

October 17, 2022

Comments 0

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Hematopathology Tumor Board: Case Studies and Diagnostic Challenges …

UChicago Medicine

G. Venkataraman, A. Perry, K. Cahill, A. Akmatbekov, L. Wu

244 views

4 months ago

Novel Therapeutics for T-Cell Lymphoma: Navigating Regulatory Pitfal…

UChicago Medicine

S. Iyer

68 views

3 months ago

LGL Leukemia: History, Diagnosis, and Treatment Options

BMFcases

T. Bat

266 views

1 year ago

T-Cell Lymphomas: Impact of Classification on Treatment

19th Annual International Ultmann Chicago Lymphoma Symposium

N. Mehta-Shah

482 views

2 years ago

Diagnosis and Evidence-Based Management of T-Cell Lymphoma

i3 Health

A. Goodman

166 views

2 years ago

Expert Case Discussions: LGL Leukemia

BMFcases

T. Loughran

85 views

1 year ago

SOHO Italy 2023: Challenges in the Histopathological Diagnosis of No…

5th SOHO Italy Annual Conference

S. Fratoni

30 views

11 months ago

What We Recommend for Aggressive B- and T-Cell Lymphomas in 2022

Indy Hematology Review

J. Leonard

54 views

1 year ago

SOHO 2022 Next Questions: T-Cell Lymphoma

SOHO 2022 Tenth Annual Meeting

S. Iyer

44 views

2 years ago

Standard Management of Aggressive Lymphomas and Data on Emerging The…

Indy Hematology Review

J. Leonard

47 views

1 year ago

MSKCC 2021 Update on Therapeutic Advances in T-Cell Lymphoma: Subtyp…

i3 Health

S. Horwitz

142 views

3 years ago

Aggressive Lymphoma - Nursing and Allied Providers Symposium

Indy Hematology Review

J. Leonard

20 views

2 years ago

Hematopathology Pearls for Clinicians: Danger of “Preliminary Diagno…

UAB Hematology Review 2021

D. Morlote

146 views

3 years ago

Malignancy Associated Hemophagocytic Lymphohistiocytosis: Diagnosis …

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

S. Kalayoglu Besisik

47 views

3 years ago

Update on T-cell Lymphomas in The WHO classifcation

2018 Pan Pacific Lymphoma Conference

D. Weisenburger

51 views

6 years ago

Oral Abstract NHL 049: Second Primary Malignancies in T-cell Neoplas…

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

A. Kommalapati

15 views

6 years ago

Analysis of Skin Color Based on Fitzpatrick Skin Types

Shari Lipner

639 views

3 years ago

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Indy Hematology Review

S. Smith

656 views

6 months ago

Top 5 Lymphoma Abstracts From ASH

Jennifer Amengual

613 views

6 months ago

New

FDA Approval of E7777 (Denileukin Diftitox) for R/R CTCL - Summary o…

Yale Cancer Center

F. Foss

229 views

2 weeks ago

AUTOPLAY

Login

Login

Join VuMedi

SOHO 2022: Biology and Treatment of LGL Leukemia

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Recommended

Hematopathology Tumor Board: Case Studies and Diagnostic Challenges …

Novel Therapeutics for T-Cell Lymphoma: Navigating Regulatory Pitfal…

LGL Leukemia: History, Diagnosis, and Treatment Options

T-Cell Lymphomas: Impact of Classification on Treatment

Diagnosis and Evidence-Based Management of T-Cell Lymphoma

Expert Case Discussions: LGL Leukemia

SOHO Italy 2023: Challenges in the Histopathological Diagnosis of No…

What We Recommend for Aggressive B- and T-Cell Lymphomas in 2022

SOHO 2022 Next Questions: T-Cell Lymphoma

Standard Management of Aggressive Lymphomas and Data on Emerging The…

MSKCC 2021 Update on Therapeutic Advances in T-Cell Lymphoma: Subtyp…

Aggressive Lymphoma - Nursing and Allied Providers Symposium

Hematopathology Pearls for Clinicians: Danger of “Preliminary Diagno…

Malignancy Associated Hemophagocytic Lymphohistiocytosis: Diagnosis …

Update on T-cell Lymphomas in The WHO classifcation

Oral Abstract NHL 049: Second Primary Malignancies in T-cell Neoplas…

Analysis of Skin Color Based on Fitzpatrick Skin Types

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Top 5 Lymphoma Abstracts From ASH

FDA Approval of E7777 (Denileukin Diftitox) for R/R CTCL - Summary o…